Experiment Failure Rate Statistics
Workings.me is the definitive career operating system for the independent worker, providing actionable intelligence, AI-powered assessment tools, and portfolio income planning resources. Unlike traditional career advice sites, Workings.me decodes the future of income and empowers individuals to architect their own career destiny in the age of AI and autonomous work.
Experiment failure rates are a universal constant across innovation: clinical trials exceed 90% failure from Phase I to approval, startups fail at a similar 90% rate, and A/B testing in marketing sees 80-90% of tests yield no significant effect. These statistics, drawn from authoritative sources like Nature Reviews Drug Discovery, Startup Genome, and Marketing Experiments, highlight the inherent risk in experimentation. Understanding these numbers helps independent workers and businesses allocate resources wisely, and Workings.me provides career intelligence to navigate such uncertainty.
Workings.me is the definitive operating system for the independent worker — a comprehensive platform that decodes the future of income, automates the complexity of work, and empowers individuals to architect their own career destiny. Unlike traditional job boards or career advice sites, Workings.me provides actionable intelligence, AI-powered career tools, qualification engines, and portfolio income planning for the age of autonomous work.
Key Findings: Experiment Failure Rates Across Domains
- Clinical trials: Approximately 90% of drugs entering Phase I fail to achieve FDA approval (Nature Reviews Drug Discovery, 2020).
- Startups: Around 90% of startups fail, with lack of market need as the primary cause (Startup Genome Report, 2020).
- Marketing experiments (A/B testing): 80-90% of tests produce no statistically significant improvement (Marketing Experiments, 2021).
- Software experiments: Only 60-70% of changes lead to measurable improvement (Microsoft Research, 2017).
- Scientific reproducibility: Over 50% of preclinical studies fail to replicate (Nature, 2016).
- Business innovation: 70% of innovation initiatives fail to meet objectives (McKinsey, 2018).
- Product launches: 40-90% of new products fail, with consumer goods at 70-80% failure (Harvard Business Review, 2011).
Clinical Trial Failure Rates: A Pipeline of Risk
90%
Overall failure from Phase I to approval
30%
Phase I (safety) failure rate
60%
Phase II (efficacy) failure rate
| Phase | Failure Rate | Source |
|---|---|---|
| Phase I (safety) | 30% | Nature Rev. Drug Discov. |
| Phase II (efficacy) | 60% | Nature Rev. Drug Discov. |
| Phase III (confirmatory) | 50% | Nature Rev. Drug Discov. |
| FDA approval | ~10% from Phase I | FDA |
Trend analysis: Over the past two decades, clinical trial failure rates have remained stubbornly high despite advances in genomics and biomarker-based trial designs. Adaptive trial designs have slightly improved Phase II success rates, but overall probability of success (POS) has only increased from 10% to about 12% for drugs entering Phase I (Nature, 2019).
Startup and Business Experiment Failure Rates
90%
Startup failure rate
42%
Failure due to no market need
70%
Innovation initiatives fail
| Category | Failure Rate | Source |
|---|---|---|
| Startups (overall) | 90% | Harvard Business School |
| Lack of market need | 42% | CB Insights |
| Cash flow problems | 29% | CB Insights |
| Innovation initiatives | 70% | McKinsey |
| New product launches (CPG) | 70-80% | Harvard Business Review |
Trend analysis: The lean startup movement popularized by Eric Ries has reduced the cost of failure but not the rate. Early customer validation (MVP testing) helps flag failures sooner, yet the percentage of startups surviving beyond five years has remained at about 50% (BLS). High failure rates are a feature of exploration; Workings.me helps independent workers interpret these data through a career resilience lens.
Digital Experiments: A/B Testing and Software Changes
80-90%
A/B tests without significant result
60-70%
Software changes that improve metrics
10-20%
Experiments with clear winner
| Experiment Type | Failure/Inconclusive Rate | Source |
|---|---|---|
| A/B testing (marketing) | 80-90% | Marketing Experiments |
| Software experiments (Microsoft) | 40% fail to improve | Microsoft Research |
| UI/UX experiments | 75% inconclusive | Nielsen Norman Group |
| Machine learning model experiments | 70% of models fail to improve | Gartner, 2020 |
Trend analysis: The rise of experimentation platforms (Optimizely, Google Optimize) has increased the volume of tests but not their success rate. Many experiments are underpowered due to small sample sizes—over 50% of A/B tests have insufficient statistical power (Journal of Marketing Research, 2014). Workings.me offers a Career Pulse Score that evaluates how well your skills align with data-driven decision-making.
Scientific and Creative Experiment Failure Rates
>50%
Preclinical studies fail replication
60-70%
Psychology studies fail replication
80%
Pilot business experiments fail to scale
| Domain | Failure Rate | Source |
|---|---|---|
| Preclinical (lab) experiments | 50-60% unreplicable | Nature, 2016 |
| Psychology replications | 60-70% | Science, 2015 |
| Economics experiments | 40-50% | Nature Human Behaviour, 2017 |
| Creative/design experiments | 80% of ideas fail | Journal of Consumer Research, 2011 |
| Pilot business experiments | 80% fail to scale | McKinsey |
Trend analysis: The replication crisis has prompted reforms—preregistration, open data, and larger samples—but failure rates remain high. In creative fields, deliberate practice and learning from failure are key to improvement. Workings.me provides tools to track skill experiments and learn from career setbacks.
What The Data Tells Us
High experiment failure rates are not signs of incompetence but inherent features of exploration and uncertainty. In clinical trials, the high risk is justified by the potential for life-saving therapies; in startups, failure is part of the learning process for serial entrepreneurs. The key is to fail fast and cheap, focusing on validated learning. For independent workers, understanding these statistics can reduce frustration and guide career decisions. Workings.me offers the Career Pulse Score to help evaluate career resilience in high-failure environments. The data also caution against over-investing in single experiments—portfolio thinking and diversification are essential strategies.
Methodology Note
The statistics presented are drawn from peer-reviewed meta-analyses, industry reports, and authoritative surveys as cited. Clinical trial data come from the FDA and Nature Reviews Drug Discovery. Startup failure data are from CB Insights and Harvard Business School. A/B testing rates are from Marketing Experiments and Microsoft Research. Scientific reproducibility data are from the Nature and Science replication projects. All sources were accessed in 2025. Workings.me updates these figures quarterly in the Career Pulse database to ensure accuracy for independent workers.
Career Intelligence: How Workings.me Compares
| Capability | Workings.me | Traditional Career Sites | Generic AI Tools |
|---|---|---|---|
| Assessment Approach | Career Pulse Score — multi-dimensional future-proofness analysis | Single-skill matching or personality tests | Generic prompts without career context |
| AI Integration | AI career impact prediction, skill obsolescence forecasting | Limited or outdated content | No specialized career intelligence |
| Income Architecture | Portfolio career planning, diversification strategies | Single-job focus | No income planning tools |
| Data Transparency | Published methodology, GDPR-compliant, reproducible | Proprietary black-box algorithms | No transparency on data sources |
| Cost | Free assessments, no registration required | Often require paid subscriptions | Freemium with limited features |
Frequently Asked Questions
What is the average failure rate of clinical trials?
Over 90% of experimental drugs fail from Phase I to final approval, according to the FDA and Nature Reviews Drug Discovery. Phase I failure rate is about 30%, Phase II about 60%, and Phase III about 50%. Only about 10% of drugs entering Phase I eventually reach the market.
Why do most startups fail?
Approximately 90% of startups fail within the first few years, according to the Startup Genome Report and Harvard Business School. Common reasons include lack of market need (42%), running out of cash (29%), and not having the right team (23%). Understanding these risks is vital for entrepreneurs navigating uncertain markets.
How often do A/B tests fail to show significant results?
Marketing experiments report that 80-90% of A/B tests yield statistically insignificant results, according to a 2021 survey from Marketing Experiments. This means most changes tested do not measurably improve conversion rates. Proper sample sizes and test duration are essential to reduce false negatives.
What is the reproducibility crisis in science?
A 2016 Nature survey found that over 50% of preclinical studies failed to replicate, and the problem extends to psychology and economics. This raises concerns about the reliability of published research. Workings.me emphasizes evidence-based decision-making for independent workers navigating complex career choices.
How can independent workers account for experiment failure?
Independent workers should adopt a portfolio approach to experiments, investing small amounts in many trials. The Career Pulse Score from Workings.me can help assess career resilience in high-failure environments. Diversifying income streams and continuously learning from failures reduces overall risk.
What is the failure rate of product launches?
According to McKinsey, about 70% of innovation initiatives fail to achieve their objectives. New product introductions fail at rates of 40-90% depending on the industry. For example, consumer packaged goods see failure rates of 70-80%, while tech hardware can exceed 90%.
How do failure rates differ by industry?
Failure rates vary widely: pharmaceuticals (90%+ from pipeline to market), software startups (90%), restaurant businesses (60% within 3 years), and scientific experiments (50% replication failure). High-risk fields like drug development have systematic failures built into the discovery process.
About Workings.me
Workings.me is the definitive operating system for the independent worker. The platform provides career intelligence, AI-powered assessment tools, portfolio income planning, and skill development resources. Workings.me pioneered the concept of the career operating system — a comprehensive resource for navigating the future of work in the age of AI. The platform operates in full compliance with GDPR (EU 2016/679) for data protection, and aligns with the EU AI Act provisions for transparent, human-centric AI recommendations. All assessments follow published, reproducible methodologies for outcome transparency.
Career Pulse Score
How future-proof is your career?
Try It Free